| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:51 UTC |
|---|
| Update Date | 2022-03-07 02:51:49 UTC |
|---|
| HMDB ID | HMDB0014988 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Perphenazine |
|---|
| Description | Perphenazine is only found in individuals that have used or taken this drug. It is an antipsychotic phenothiazine derivative with actions and uses similar to those of chlorpromazine. [PubChem]Binds to the dopamine D1 and dopamine D2 receptors and inhibits their activity. The mechanism of the anti-emetic effect is due predominantly to blockage of the dopamine D2 neurotransmitter receptors in the chemoreceptor trigger zone and vomiting centre. Perphenazine also binds the alpha andrenergic receptor. This receptor's action is mediated by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. |
|---|
| Structure | OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1 InChI=1S/C21H26ClN3OS/c22-17-6-7-21-19(16-17)25(18-4-1-2-5-20(18)27-21)9-3-8-23-10-12-24(13-11-23)14-15-26/h1-2,4-7,16,26H,3,8-15H2 |
|---|
| Synonyms | | Value | Source |
|---|
| 2-(4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol | ChEBI | | 2-Chloro-10-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)phenothiazine | ChEBI | | 4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol | ChEBI | | 4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol | ChEBI | | Chlorpiprazine | ChEBI | | gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine | ChEBI | | Perfenazina | ChEBI | | Perfenazine | ChEBI | | Perphenazin | ChEBI | | Perphenazinum | ChEBI | | Trilafon | ChEBI | | 4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol | Kegg | | g-(4-(b-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine | Generator | | Γ-(4-(β-hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine | Generator | | Chlorperphenazine | HMDB | | Etaperazin | HMDB | | Etaperazine | HMDB | | Ethaperazine | HMDB | | PZC | HMDB |
|
|---|
| Chemical Formula | C21H26ClN3OS |
|---|
| Average Molecular Weight | 403.969 |
|---|
| Monoisotopic Molecular Weight | 403.148510866 |
|---|
| IUPAC Name | 2-{4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethan-1-ol |
|---|
| Traditional Name | perphenazine |
|---|
| CAS Registry Number | 58-39-9 |
|---|
| SMILES | OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1 |
|---|
| InChI Identifier | InChI=1S/C21H26ClN3OS/c22-17-6-7-21-19(16-17)25(18-4-1-2-5-20(18)27-21)9-3-8-23-10-12-24(13-11-23)14-15-26/h1-2,4-7,16,26H,3,8-15H2 |
|---|
| InChI Key | RGCVKNLCSQQDEP-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as phenothiazines. These are polycyclic aromatic compounds containing a phenothiazine moiety, which is a linear tricyclic system that consists of a two benzene rings joined by a para-thiazine ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Benzothiazines |
|---|
| Sub Class | Phenothiazines |
|---|
| Direct Parent | Phenothiazines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Phenothiazine
- Alkyldiarylamine
- Diarylthioether
- Aryl thioether
- Tertiary aliphatic/aromatic amine
- N-alkylpiperazine
- Para-thiazine
- Aryl chloride
- Aryl halide
- 1,4-diazinane
- Piperazine
- Benzenoid
- Tertiary amine
- Tertiary aliphatic amine
- 1,2-aminoalcohol
- Azacycle
- Thioether
- Alkanolamine
- Organic oxygen compound
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Organooxygen compound
- Alcohol
- Organic nitrogen compound
- Amine
- Primary alcohol
- Organopnictogen compound
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 97 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.024 g/L | Not Available | | LogP | 3.9 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 3.07 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.8063 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.16 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 85.4 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 974.1 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 197.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 170.3 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 177.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 102.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 410.7 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 505.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 531.6 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1006.2 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 303.9 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1058.0 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 264.9 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 358.2 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 322.3 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 347.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 100.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental GC-MS | GC-MS Spectrum - Perphenazine EI-B (Non-derivatized) | splash10-0006-9450000000-c13808005c7ad3a43067 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Perphenazine EI-B (Non-derivatized) | splash10-0006-9450000000-c13808005c7ad3a43067 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Perphenazine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0095-9657000000-60700e1919a2a347a71b | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Perphenazine GC-MS (1 TMS) - 70eV, Positive | splash10-0229-9487500000-73c379ba5c6abc82840d | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Perphenazine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Perphenazine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | MS | Mass Spectrum (Electron Ionization) | splash10-0002-4591100000-97d36958b3e0fe519db6 | 2014-09-20 | Not Available | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Perphenazine LC-ESI-qTof , Positive-QTOF | splash10-0f6t-2930000000-57d820b40a3c2c072840 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Perphenazine , positive-QTOF | splash10-0zfr-0410900000-0910eefd789edd7f94c9 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Perphenazine , positive-QTOF | splash10-006x-3940100000-e722b009e1511bd2bb57 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Perphenazine , positive-QTOF | splash10-0f6t-2930000000-57d820b40a3c2c072840 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Perphenazine 10V, Positive-QTOF | splash10-0udi-0212900000-26811bdbf39c3e1f8128 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Perphenazine 20V, Positive-QTOF | splash10-0fki-3948400000-a80b04752eda36cb7edb | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Perphenazine 40V, Positive-QTOF | splash10-0aej-8951000000-b1b95a17c6520a72fbcf | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Perphenazine 10V, Negative-QTOF | splash10-0udi-0004900000-610370bca54ab9e9c9d6 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Perphenazine 20V, Negative-QTOF | splash10-0kal-0092100000-d3e759bb26e17fa9ca6c | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Perphenazine 40V, Negative-QTOF | splash10-001i-6790000000-a28fc2d16e6ed9427ab6 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Perphenazine 10V, Positive-QTOF | splash10-0udi-0000900000-fdd66a3be8cc27f249df | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Perphenazine 20V, Positive-QTOF | splash10-0udi-0311900000-06e01a3d1767fa33c605 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Perphenazine 40V, Positive-QTOF | splash10-0h7r-2925000000-d9a982d7b5cbf608d58c | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Perphenazine 10V, Negative-QTOF | splash10-0udi-0000900000-63d2610cf91fae71d084 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Perphenazine 20V, Negative-QTOF | splash10-0fk9-0019400000-5b6c925124075a568e5f | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Perphenazine 40V, Negative-QTOF | splash10-001i-9065100000-6329f86de2658ba85f88 | 2021-10-11 | Wishart Lab | View Spectrum |
|
|---|